Axsome Therapeutics Inc

Key Account Manger, Kitakanto-Koshin-Hokuriku Area

Japan

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, PharmaceuticalIndustries

Key Account Manager

Position Overview

The Key Account Manager is a field-based position responsible for serving as a direct link between PTC Therapeutics and Healthcare Providers (HCPs) and clients within an assigned geographic region. This role collaborates closely with the Regional Head and regional Commercial & Medical teams to represent PTC's products to medical professionals specializing in Neurology and Metabolic therapeutic areas. The Key Account Manager manages all operational aspects of pharmaceutical sales and service, including sales generation, communication of clinical and economic benefits, relationship building, customer education, and identification of growth opportunities. This role also involves cross-functional collaboration with internal departments and external resources on sales-related issues and adherence to regulatory requirements and company SOPs.

Company Information

PTC Therapeutics is a global commercial biopharmaceutical company with over 25 years of commitment to extending life’s moments for children and adults living with rare diseases. PTC cultivates an inclusive culture where everyone feels valued, respected, and empowered, welcoming candidates from all backgrounds.

Responsibilities

  • Establishes, develops, and maintains business partnerships with targeted HCPs and staff within the assigned geographical territory.
  • Increases awareness through appropriate scientific information and education programs for medical professionals, patients, and families.
  • Develops and executes a region-specific, integrated action plan across the communication mix to achieve defined territory and sales goals.
  • Clearly understands and implements account/marketing plan goals to attain sales/patient objectives for assigned products.
  • Creates consultative, solution-oriented business partnerships by understanding customer needs and how PTC products can meet them.
  • Identifies key treatment versus referral centers and facilitates cross-collaboration to optimize patient care.
  • Drives patient identification initiatives.
  • Establishes, manages, and maintains successful relations with relevant health authorities, Key Opinion Leaders (KOLs), HCPs, and payors.
  • Identifies and resolves product access and reimbursement issues.
  • Provides training and assistance to HCPs and hospital staff regarding indicated diseases and product usage.
  • Communicates effects, side effects, and contraindications/risks of drugs according to proper timelines and notifies the Pharmacovigilance (PV) Department.
  • Maintains current and comprehensive clinical and pharmacoeconomic knowledge of the product and treatment area.
  • Collaborates with commercial and scientific colleagues to share best practices and drive commercial business.
  • Creates account plans and provides feedback for business reviews and ad hoc analysis.
  • Performs other tasks and assignments as needed and specified by management.

Requirements

  • Experience working in a small, fast-growing, entrepreneurial orphan/rare disease organization launching innovative therapies is preferred.
  • Bachelor’s degree in a related business or scientific field.

Employment Type

  • Full time

Location Type

  • Field Based (Specific location not provided)

Salary

  • Not specified

Skills

Pharmaceutical Sales
Relationship Building
Scientific Information
Neurology
Metabolic Disorders
Sales Operations
Client Relations

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI